MENU
NGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NervGen Pharma (NGEN) Earnings Date & Reports
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions... Show more
A.I. Advisor
published Earnings
NGEN is expected to report earnings to fall 72.38% to -7 cents per share on November 12
Q3'26
Est.
$-0.07
Q2'26
Missed
by $0.20
Q1'26
Beat
by $0.06
Q4'25
Missed
by $0.22
The last earnings report on August 13 showed earnings per share of -26 cents, missing the estimate of -6 cents. With 373.20K shares outstanding, the current market capitalization sits at 199.99M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information